MicroRNA Sequencing Data Analysis Toolkits

Part of the Methods in Molecular Biology book series (MIMB, volume 1699)


MicroRNA (miRNA) is a non-protein-coding small RNA molecule that negatively regulates gene expression by degradation of mRNA or suppression of mRNA translation. MiRNAs play important roles in biological processes such as cellular development, differentiation, proliferation, apoptosis and stem cell self-renewal and cancer development. The expression profile of microRNAs is tissue-, cell-type specific. PCR- and microarray-based arrays are the commonly used for differential expression of microRNAs between different diseased conditions. With the next-generation sequencing or massively parallel DNA sequencing technology advanced and the cost is plummeting, microRNAseq approach is widely used for the genome-wide discovery of known and unknown miRNA expression. However, the analysis of microRNAseq is computational expensive, here I provide guidelines and available tools for microRNAseq analysis.

Key words

microRNA microRNAseq Massively parallel DNA sequencing Bioinformatics Data analysis 


  1. 1.
    Wilbert ML, Yeo GW (2011) Genome-wide approaches in the study of microRNA biology. Wiley Interdiscip Rev Syst Biol Med 3:491–512CrossRefPubMedGoogle Scholar
  2. 2.
    Wu W, Sun M, Zou GM, Chen J (2006) MicroRNA and cancer: current status and prospective. Int J Cancer 120(5):953–960CrossRefGoogle Scholar
  3. 3.
    Watanabe Y, Kanai A (2011) Systems biology reveals MicroRNA-mediated gene regulation. Front Genet 2:29CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18:350–359CrossRefPubMedGoogle Scholar
  5. 5.
    Wu W (2011) MicroRNA and cancer. Methods Mol Biol 676:59–70CrossRefPubMedGoogle Scholar
  6. 6.
    Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR et al (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103:9136–9141CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS et al (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48–57CrossRefPubMedGoogle Scholar
  8. 8.
    Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS et al (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115:2630–2639CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wu W, Cao W, Chan JA (2013) Regulation of MicroRNAs for potential cancer therapeutics:the paradigm shift from pathways to perturbation of gene regulatory networks. In: Lopez-Camarillo C, Marchat LA (eds) MicroRNAs in cancer. CRC Press, Boca Raton, FL, pp 364–386CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Department of Medicine, Helen Diller Family Comprehensive Cancer CenterUniversity of California in San FranciscoSan FranciscoUSA

Personalised recommendations